Diffusion of tranexamic acid to the joint.
Tranexamic acid (Cyklokapron, Kabi, Stockholm) in a dose of 10 mg per kg body weight was given i.v. to 17 patients at various intervals before operation on the knee joint, in order to elucidate the diffusion of the drug to the joint fluid and the synovial membrane. The acid diffused rapidly to both the above tissues, and in the joint fluid it reached the same concentration as in the serum. The biologic half-time in the joint fluid was about 3 hours. In the treatment of joint bleedings in hemophiliacs and in association with intra-articular operations on such patients tranexamic acid is a suitable supplement to conventional substitution therapy.
D000328:Adult; D000368:Aged; D001826:Body Fluids / Q000032:analysis; D003509:Cyclohexanecarboxylic Acids / Q000378:metabolism*; D004058:Diffusion; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007719:Knee Joint / Q000378:metabolism* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D000074402:Synovectomy; D013583:Synovial Membrane / Q000378:metabolism*; D014148:Tranexamic Acid / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid